With the help of patients’ material, researchers from the German Center for Neurodegenerative Diseases (DZNE) and the Hertie Institute for Clinical Brain Research in Tübingen have found out that people with a variant of the gene GBA1 bear an increased risk of developing Parkinson's disease.

Human schizophrenia “model”

Friday, 04 July 2014 21:33

According to a press release by scientists from the University of Bonn, 24 hours of sleep deprivation lead to schizophrenia-like symptoms in humans.

Lab on a Chip in Droplet Form

Monday, 30 June 2014 21:32

Researchers at ETH Zurich have developed a new miniature in vitro system that uses spherical organ-like structures of different cell types cultured in hanging drops and linked together.

The Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) is one of 11 partners in the European PneumoNP project and will contribute to research with in vitro studies.

Inaugural EU-NETVAL meeting

Thursday, 26 June 2014 21:28

The European Union Network of Laboratories for the Validation of Alternative Methods to Animal Experiments (European NETVAL) convened for its inaugural session on 26 and 27 June 2014.

CAAT honoured with Act4Animals award

Monday, 23 June 2014 21:05

Prof. Dr. Dr. Thomas Hartung and the Center for Alternatives to Animal Testing (CAAT) have been honoured by the Eurogroup for Animals with an Act4Animals award for their long-lasting commitment to replacing animal experiments. Eurogroup for Animals is a European animal welfare initiative comprising various national animal protection organisations.

The dopamine pump of Parkinson´s sufferers is less effective at pumping out dopamine and storing it in the brain cells. If dopamine is not stored correctly, however, it can cause self-destruction of the affected nerve cells.

In their recent essay in the open access Journal BMJ (previously British Medical Journal), Dr. Pandora Pound from the School of Social and Community Medicine in Bristol, UK, and Michael Bracken, Susan Dwight Bliss Professor for Epidemiology at the Yale School of Public Health, New Haven, Connecticut, USA, take a critical look at animal models and their possible transferability to humans.

National cohort study started

Tuesday, 17 June 2014 20:59

In May the largest German health study with 200,000 volunteers started work at the Study Centre Hannover. As of October the study will start nationwide.

American scientists headed by Sue O'Shea, professor in the Department of Cell & Developmental Biology and director of the U-M Pluripotent Stem Cell Research Lab, and Melvin McInnis, the Upjohn Woodworth Professor of Bipolar Disorder and Depression in the Department of Psychiatry at The University of Michigan, have successfully used induced pluripotent stem cells to reveal important genetic background information on bipolar disorders.